In recent months, the federal government has begun rolling out a new generation of coronavirus vaccines that contain a strain of a virus that has not yet been found in humans.
The new vaccine is called CRISPR-Cas9 and was developed by scientists at the University of California, San Francisco.
It has not been approved for human use, but scientists have been testing the vaccine in animals and humans for several months.
The CRISP-Cas 9 vaccine was developed at the Massachusetts Institute of Technology and is the first vaccine to be made from the modified version of a viral gene that is not found in viruses.
It is designed to target a different form of the virus, known as a coronaviruses genetic material, which is not present in human cells.
The company behind the vaccine says the vaccine has shown great promise and has been approved by the Food and Drug Administration for use in humans in a trial.
The vaccine is designed specifically to treat the coronaviral infection caused by the coronavia virus, which can cause severe complications such as pneumonia and death.
The vaccine does not contain any live viruses.